1.Toll-like receptor 9 dependent activation of MAPK and NF-kB is required for the CpG ODN-induced matrix metalloproteinase-9 expression.
Eun Jung LIM ; Sun Hye LEE ; Jin Gu LEE ; Jae Ryong KIM ; Sung Su YUN ; Suk Hwan BAEK ; ChuHee LEE
Experimental & Molecular Medicine 2007;39(2):239-245
		                        		
		                        			
		                        			Unmethylated CpG oligodeoxynucleotides (CpG ODNs) activate immune cells to produce immune mediators. This study demonstrates that in murine macrophage RAW 264.7 cells, CpG ODN-mediated matrix metalloproteinase-9 (MMP-9) expression is regulated at transcriptional level and requires de novo protein synthesis. Inhibition of ERK and p38 MAPK, but not JNK, results in significant decrease of CpG ODN-induced MMP-9 expression. We found that endosomal maturation inhibitors, chloroquine and bafilomycin A, block CpG ODN-induced ERK and p38 MAPK activation and the subsequent MMP-9 expression. We also observed that CpG ODN induces NF-kappa B activation and NF-kappa B is a downstream target of p38 MAPK. Taken together, our data demonstrate that CpG ODN triggers MMP-9 expression via TLR-9 dependent ERK and p38 MAPK activation followed by NF-kappa B activation.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Cell Line
		                        			;
		                        		
		                        			Enzyme Activation/drug effects
		                        			;
		                        		
		                        			Enzyme Induction/drug effects
		                        			;
		                        		
		                        			Matrix Metalloproteinase 9/*biosynthesis
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mitogen-Activated Protein Kinase 1/antagonists & inhibitors/metabolism
		                        			;
		                        		
		                        			Mitogen-Activated Protein Kinase 3/antagonists & inhibitors/metabolism
		                        			;
		                        		
		                        			Mitogen-Activated Protein Kinases/*metabolism
		                        			;
		                        		
		                        			NF-kappa B/*metabolism
		                        			;
		                        		
		                        			Oligodeoxyribonucleotides/*pharmacology
		                        			;
		                        		
		                        			Signal Transduction/drug effects
		                        			;
		                        		
		                        			Toll-Like Receptor 9/antagonists & inhibitors/*metabolism
		                        			;
		                        		
		                        			p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors/metabolism
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail